Tradename | Company | Number | Date | Products |
---|---|---|---|---|
AGGRENOX | Boehringer Ingelheim | N-020884 DISCN | 1999-11-22 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NORGESIC | Bausch Health Companies | N-013416 DISCN | 1982-10-27 | 1 products, RLD |
NORGESIC FORTE | Bausch Health Companies | N-013416 DISCN | 1982-10-27 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
YOSPRALA | Genus Lifesciences | N-205103 DISCN | 2016-09-14 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VAZALORE | PLx Pharma | N-203697 OTC | 2013-01-14 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EQUAGESIC | Sun Pharmaceutical Industries | N-011702 DISCN | 1983-12-29 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
SYNALGOS-DC | Sun Pharmaceutical Industries | N-011483 DISCN | 1983-09-06 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PRAVIGARD PAC (COPACKAGED) | Bristol Myers Squibb | N-021387 DISCN | 2003-06-24 | 6 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DARVON W/ ASA | Xanodyne Pharmaceuticals | N-010996 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DARVON COMPOUND | Xanodyne Pharmaceuticals | N-010996 DISCN | 1983-03-08 | 1 products |
DARVON COMPOUND-65 | Xanodyne Pharmaceuticals | N-010996 DISCN | 1983-03-08 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ROBAXISAL | A.H. Robins Company | N-012281 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
10 person ansi | OTC monograph final | 2010-06-07 |
25 person ansi | OTC monograph final | 2010-06-07 |
50 person ansi | OTC monograph final | 2010-06-07 |
acetaminophen 250mg aspirin 250mg caffeine 65mg | C200263 | 2024-12-26 |
acetaminophen aspirin and caffeine | C200263 | 2025-10-01 |
acetaminophen aspirin caffeine | ANDA | 2024-11-18 |
acetaminophen, aspirin and caffeine | C200263 | 2025-07-03 |
acetaminophen, aspirin, and caffeine | C200263 | 2025-07-02 |
acetaminophen, aspirin, caffeine | C200263 | 2025-02-11 |
acetylsalicylic acid | Export only | 2025-01-15 |
Code | Description |
---|---|
G2128 | Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period) |
G8598 | Aspirin or another antiplatelet therapy used |
G8599 | Aspirin or another antiplatelet therapy not used, reason not given |
G9277 | Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux) |
G9278 | Documentation that the patient is not on daily aspirin or anti-platelet regimen |
G9793 | Patient is currently on a daily aspirin or other antiplatelet |
G9794 | Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period) |
G9795 | Patient is not currently on a daily aspirin or other antiplatelet |
M1055 | Aspirin or another antiplatelet therapy used |
M1056 | Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coronary artery disease | D003324 | — | I25.1 | 8 | 13 | 23 | 120 | 104 | 267 |
Stroke | D020521 | EFO_0000712 | I63.9 | 4 | 26 | 71 | 43 | 60 | 187 |
Ischemic stroke | D000083242 | — | — | 7 | 26 | 51 | 37 | 44 | 150 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | 3 | 13 | 30 | 46 | 45 | 129 |
Infarction | D007238 | EFO_0009463 | — | 5 | 12 | 29 | 43 | 45 | 127 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | 2 | 7 | 14 | 52 | 51 | 126 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | 8 | 12 | 14 | 51 | 36 | 120 |
Coronary disease | D003327 | — | — | 3 | 6 | 12 | 48 | 50 | 118 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 11 | 16 | 25 | 25 | 43 | 117 |
Ischemia | D007511 | EFO_0000556 | — | 5 | 17 | 25 | 24 | 34 | 93 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 3 | 14 | 10 | — | 10 | 34 |
Duodenal ulcer | D004381 | EFO_0004607 | K26 | 2 | 3 | 9 | — | 6 | 18 |
Multiple myeloma | D009101 | — | C90.0 | 7 | 8 | 5 | — | 1 | 16 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 9 | 3 | — | 2 | 15 |
Stomach ulcer | D013276 | — | K25 | — | 2 | 10 | — | 4 | 15 |
Colonic neoplasms | D003110 | — | C18 | — | 2 | 5 | — | 4 | 11 |
Pneumonia | D011014 | EFO_0003106 | J18 | 1 | 2 | 4 | — | 4 | 10 |
Non-small-cell lung carcinoma | D002289 | — | — | 2 | 4 | 2 | — | 2 | 9 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 6 | 1 | — | 1 | 9 |
Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | 2 | 3 | — | 3 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Plasma cell neoplasms | D054219 | — | — | 6 | 6 | — | — | 1 | 10 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 7 | — | — | — | 7 |
Hiv | D006678 | — | O98.7 | — | 3 | — | — | 3 | 6 |
Drug resistance | D004351 | — | Z16.30 | 1 | 1 | — | — | 4 | 5 |
Triple negative breast neoplasms | D064726 | — | — | 1 | 4 | — | — | — | 4 |
High-risk pregnancy | D018566 | — | — | — | 2 | — | — | 2 | 4 |
Obstructive lung diseases | D008173 | — | — | — | 4 | — | — | — | 4 |
Rectal neoplasms | D012004 | — | — | — | 2 | — | — | 2 | 4 |
Tobacco use disorder | D014029 | — | F17 | 1 | 3 | — | — | — | 4 |
Rhinosinusitis | D000096825 | — | — | 1 | 1 | — | — | 3 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 1 | — | — | — | 12 | 13 |
Blood platelet disorders | D001791 | — | — | 1 | — | — | — | 4 | 5 |
Respiratory aspiration | D053120 | EFO_1001839 | — | 3 | — | — | — | 1 | 4 |
Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
Smoking | D012907 | EFO_0004318 | — | 1 | — | — | — | 2 | 3 |
Sleep initiation and maintenance disorders | D007319 | — | F51.01 | 1 | — | — | — | 2 | 3 |
Pharmacokinetics | D010599 | — | — | 3 | — | — | — | — | 3 |
Aging | D000375 | GO_0007568 | R41.81 | 1 | — | — | — | 1 | 2 |
Optical coherence tomography | D041623 | — | — | 1 | — | — | — | 1 | 2 |
Fallopian tube neoplasms | D005185 | — | — | 2 | — | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Asymptomatic diseases | D058070 | — | — | — | — | — | — | 5 | 5 |
Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | — | — | 4 | 4 |
Hemostatic disorders | D020141 | — | — | — | — | — | — | 4 | 4 |
Coronary occlusion | D054059 | — | I21 | — | — | — | — | 3 | 3 |
Coagulation protein disorders | D020147 | — | — | — | — | — | — | 3 | 3 |
Thrombectomy | D017131 | — | — | — | — | — | — | 3 | 3 |
Gastrointestinal neoplasms | D005770 | — | C26.9 | — | — | — | — | 3 | 3 |
Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | — | — | — | — | 3 | 3 |
Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | — | — | — | — | 3 | 3 |
Postoperative complications | D011183 | — | — | — | — | — | — | 3 | 3 |
Drug common name | Aspirin |
INN | carisoprodol |
Description | Acetylsalicylic acid is a member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a platelet aggregation inhibitor, an antipyretic, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, a prostaglandin antagonist, a teratogenic agent, an anticoagulant, a plant activator, an EC 1.1.1.188 (prostaglandin-F synthase) inhibitor, a drug allergen and a geroprotector. It is a member of benzoic acids, a member of salicylates and a member of phenyl acetates. It is functionally related to a salicylic acid. It is a conjugate acid of an acetylsalicylate. |
Classification | Small molecule |
Drug class | Nonsteroidal anti-inflammatory drug (NSAID) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)Oc1ccccc1C(=O)O |
PDB | — |
CAS-ID | 50-78-2 |
RxCUI | — |
ChEMBL ID | CHEMBL25 |
ChEBI ID | 15365 |
PubChem CID | 2244 |
DrugBank | DB00945 |
UNII ID | R16CO5Y76E (ChemIDplus, GSRS) |